Israel Englander Anika Therapeutics, Inc. Transaction History

Millennium Management LLC

$192 Billion
Q2 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 133,673 shares of ANIK stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

133,673

Previous 77,548 72.37%

Holding current value

$1.17 Million

Previous $1.17 Million 21.37%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$10.58 - $15.05 $593,802 - $844,681	56,125 Added 72.37%	133,673 $1.41 Million
Q1 2025 May 15, 2025	BUY	$15.03 - $17.97 $782,236 - $935,248	52,045 Added 204.07%	77,548 $1.17 Million
Q4 2024 Feb 14, 2025	SELL	$16.04 - $25.53 $224,656 - $357,573	-14,006 Reduced 35.45%	25,503 $419,000
Q3 2024 Nov 14, 2024	BUY	$24.25 - $28.75 $213,327 - $252,913	8,797 Added 28.64%	39,509 $975,000
Q2 2024 Aug 14, 2024	SELL	$24.57 - $28.47 $2.1 Million - $2.43 Million	-85,381 Reduced 73.55%	30,712 $777,000
Q1 2024 May 15, 2024	SELL	$21.95 - $26.42 $4.64 Million - $5.59 Million	-211,549 Reduced 64.57%	116,093 $2.95 Million
Q4 2023 Feb 14, 2024	BUY	$18.47 - $23.3 $3.64 Million - $4.59 Million	196,866 Added 150.54%	327,642 $7.42 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $28.86 $3.09 Million - $3.54 Million	122,659 Added 1511.14%	130,776 $3.4 Million
Q1 2023 May 15, 2023	SELL	$25.91 - $32.1 $3.16 Million - $3.91 Million	-121,844 Reduced 93.75%	8,117 $233,000
Q4 2022 Feb 14, 2023	BUY	$23.85 - $31.91 $2.86 Million - $3.83 Million	120,092 Added 1216.86%	129,961 $3.85 Million
Q3 2022 Nov 14, 2022	SELL	$21.74 - $24.68 $586,893 - $666,261	-26,996 Reduced 73.23%	9,869 $235,000
Q2 2022 Aug 15, 2022	BUY	$20.4 - $25.53 $752,046 - $941,163	36,865 New	36,865 $823,000
Q1 2022 May 16, 2022	SELL	$24.7 - $36.54 $749,027 - $1.11 Million	-30,325 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$35.83 - $45.03 $32,927 - $41,382	-919 Reduced 2.94%	30,325 $1.09 Million
Q3 2021 Nov 15, 2021	SELL	$38.75 - $44.47 $511,810 - $587,359	-13,208 Reduced 29.71%	31,244 $1.33 Million
Q2 2021 Aug 16, 2021	SELL	$39.42 - $48.08 $3.11 Million - $3.79 Million	-78,874 Reduced 63.96%	44,452 $1.92 Million
Q1 2021 May 17, 2021	BUY	$32.49 - $45.96 $3.22 Million - $4.55 Million	99,036 Added 407.72%	123,326 $5.03 Million
Q4 2020 Feb 16, 2021	BUY	$32.59 - $45.26 $791,611 - $1.1 Million	24,290 New	24,290 $1.1 Million
Q2 2020 Aug 14, 2020	SELL	$27.83 - $37.73 $1.65 Million - $2.23 Million	-59,236 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$22.38 - $54.06 $823,091 - $1.99 Million	-36,778 Reduced 38.3%	59,236 $1.71 Million
Q4 2019 Feb 14, 2020	SELL	$51.85 - $73.36 $4.97 Million - $7.04 Million	-95,947 Reduced 49.98%	96,014 $4.98 Million
Q3 2019 Nov 14, 2019	SELL	$40.05 - $57.47 $3.88 Million - $5.57 Million	-96,864 Reduced 33.54%	191,961 $10.5 Million
Q2 2019 Aug 15, 2019	BUY	$30.3 - $41.14 $1.89 Million - $2.56 Million	62,268 Added 27.48%	288,825 $11.7 Million
Q1 2019 May 14, 2019	BUY	$29.37 - $40.49 $1.06 Million - $1.46 Million	36,009 Added 18.9%	226,557 $6.85 Million
Q4 2018 Feb 14, 2019	BUY	$30.16 - $43.0 $3 Million - $4.27 Million	99,387 Added 109.02%	190,548 $6.4 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $42.51 $897,112 - $1.16 Million	27,326 Added 42.81%	91,161 $3.85 Million
Q2 2018 Aug 14, 2018	BUY	$28.77 - $48.27 $587,483 - $985,673	20,420 Added 47.03%	63,835 $2.04 Million
Q1 2018 May 15, 2018	BUY	$49.22 - $68.43 $1.95 Million - $2.71 Million	39,554 Added 1024.45%	43,415 $2.16 Million
Q4 2017 Feb 14, 2018	SELL	$52.14 - $59.94 $207,621 - $238,681	-3,982 Reduced 50.77%	3,861 $208,000
Q3 2017 Nov 14, 2017	BUY	$51.16 - $58.21 $401,247 - $456,541	7,843	7,843 $455,000

Others Institutions Holding ANIK

# of Institutions

105

Shares Held

11.4M

Call Options Held

Put Options Held

View Full List

About Anika Therapeutics, Inc.

Ticker ANIK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,599,900
Market Cap $127M
Description
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...

More about ANIK

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account